1. Home
  2. AMST vs ENVB Comparison

AMST vs ENVB Comparison

Compare AMST & ENVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Amesite Inc.

AMST

Amesite Inc.

HOLD

Current Price

$0.88

Market Cap

6.1M

Sector

Technology

ML Signal

HOLD

Logo Enveric Biosciences Inc.

ENVB

Enveric Biosciences Inc.

SELL

Current Price

$1.39

Market Cap

6.7M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
AMST
ENVB
Founded
N/A
1994
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.1M
6.7M
IPO Year
2020
2000

Fundamental Metrics

Financial Performance
Metric
AMST
ENVB
Price
$0.88
$1.39
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
74.7K
★ 75.1K
Earning Date
10-27-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 38.83
N/A
EPS
★ N/A
N/A
Revenue
$364,777.00
★ $39,914,675.00
Revenue This Year
$19,089.81
N/A
Revenue Next Year
$22.86
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 230.24
N/A
52 Week Low
$0.77
$1.17
52 Week High
$3.90
$795.00

Technical Indicators

Market Signals
Indicator
AMST
ENVB
Relative Strength Index (RSI) 37.17 41.25
Support Level $0.77 $1.17
Resistance Level $1.11 $1.53
Average True Range (ATR) 0.04 0.09
MACD -0.01 -0.01
Stochastic Oscillator 25.56 28.26

Price Performance

Historical Comparison
AMST
ENVB

About AMST Amesite Inc.

Amesite Inc is a technology company focused on building and commercializing AI (artificial intelligence)-powered solutions for the enterprise and for professionals, with particular emphasis on the post-acute healthcare market. It operates through two product lines: NurseMagic and LynkMagic. NurseMagic solutions include a B2B (business-to-business) enterprise application and a B2C (business-to-consumer) solution for individual healthcare professionals. LynkMagic provides enterprise AI solutions for healthcare and related organizations. Its products support documentation, workflow, compliance, oversight, and are designed to improve operational quality and efficiency. It has one single operating and reporting segment, B2C and B2B AI-driven solutions.

About ENVB Enveric Biosciences Inc.

Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company's program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. The company is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, which is being studied as a treatment for psychiatric disorders.

Share on Social Networks: